BioClinica®, Inc. Company Profile
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica solutions maximize efficiency and manageability throughout all phases of the clinical trial process. With over 20 years of experience and more than 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.
News Articles
BioClinica and CoreLab Partners Merge
BioClinica ®, Inc., a global provider of clinical trial management services, announced today that JLL Partners and Ampersand Capital Partners, two leading middle market private equity firms, have com...
N.Y. Equity Firm to Buy Bioclinica, Corelab Partners
N.Y. Equity Firm to Buy Bioclinica, Corelab Partners [the Philadelphia Inquirer] From Philadelphia Inquirer (PA) (January 31, 2013) Jan. 31--Bucks County-based BioClinica, Inc., which handles imaging...
MILWAUKEE, Jan. 30, 2013 (GLOBE NEWSWIRE) -- Ademi & O'Reilly, LLP is investigating the Board of Directors of BioClinica®, Inc. ("BioClinica®" or the "Company") for possible breaches of fiducia...
TauRx chooses BioClinica eClinical and imaging solutions
TauRx Therapeutics, a Singapore-based company, has selected BioClinica's Trident IWR/IVR solution to use in a series of expanded Phase III trials for its pipeline of neurology treatment candidates.
TauRx chooses BioClinica for eClinical, imaging solutions
Singapore-based company TauRx Therapeutics has selected BioClinica's Trident IWR/IVR solution to use in a series of expanded Phase III trials for its pipeline of neurology treatment candidates.
BioClinica: A Stealth Stock For Savvy Buyers?
By James Stocklasar Thomas Jr.:I am perplexed by BioClinica (BIOC). Cash flow positive. Recently signed a big deal with Sanofi (SNY). 51% institutional ownership. Bullish buying all year. S...
Finkelstein Thompson LLP Announces Investigation of BioClinica, Inc.
The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of BioClinica, Inc. (NASDAQ: BIOC) (“BioClinica” or “the Company”), conce...
Rigrodsky & Long, P.A. Announces Investigation Of BioClinica, Inc. Buyout
Rigrodsky & Long, P.A.: Do you own shares of BioClinica, Inc. (NASDAQ GM: BIOC)? Did you purchase any of your shares prior to January 30, 2013...
Drugs and Medications
None
PubMed Articles
To achieve minimal inter-observer variability in assessment of spleen and liver volume changes using a novel MRI reading method in the context of a phase III clinical trial of a new therapy for Gauche...
Clinical Trials
None
Companies
BioClinica, Inc. is a global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with...
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovati...
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovat...
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovat...
Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of BioClinica, Inc. (âBioClinicaâ or the âCom...
More Information about "BioClinica®, Inc." on BioPortfolio
We have published hundreds of BioClinica®, Inc. news stories on BioPortfolio along with dozens of BioClinica®, Inc. Clinical Trials and PubMed Articles about BioClinica®, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioClinica®, Inc. Companies in our database. You can also find out about relevant BioClinica®, Inc. Drugs and Medications on this site too.
